1. Home
  2. APLT vs CPSS Comparison

APLT vs CPSS Comparison

Compare APLT & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • CPSS
  • Stock Information
  • Founded
  • APLT 2016
  • CPSS 1991
  • Country
  • APLT United States
  • CPSS United States
  • Employees
  • APLT N/A
  • CPSS N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • CPSS Finance: Consumer Services
  • Sector
  • APLT Health Care
  • CPSS Finance
  • Exchange
  • APLT Nasdaq
  • CPSS Nasdaq
  • Market Cap
  • APLT 178.6M
  • CPSS 164.5M
  • IPO Year
  • APLT 2019
  • CPSS 1992
  • Fundamental
  • Price
  • APLT $1.15
  • CPSS $8.40
  • Analyst Decision
  • APLT Buy
  • CPSS
  • Analyst Count
  • APLT 5
  • CPSS 0
  • Target Price
  • APLT $4.13
  • CPSS N/A
  • AVG Volume (30 Days)
  • APLT 3.2M
  • CPSS 28.4K
  • Earning Date
  • APLT 11-10-2025
  • CPSS 11-06-2025
  • Dividend Yield
  • APLT N/A
  • CPSS N/A
  • EPS Growth
  • APLT N/A
  • CPSS N/A
  • EPS
  • APLT N/A
  • CPSS 0.80
  • Revenue
  • APLT $121,000.00
  • CPSS $192,257,000.00
  • Revenue This Year
  • APLT N/A
  • CPSS $143.76
  • Revenue Next Year
  • APLT $5,935.35
  • CPSS $14.32
  • P/E Ratio
  • APLT N/A
  • CPSS $10.50
  • Revenue Growth
  • APLT N/A
  • CPSS 2.04
  • 52 Week Low
  • APLT $0.30
  • CPSS $6.67
  • 52 Week High
  • APLT $10.62
  • CPSS $12.73
  • Technical
  • Relative Strength Index (RSI)
  • APLT 53.11
  • CPSS 58.89
  • Support Level
  • APLT $1.08
  • CPSS $7.61
  • Resistance Level
  • APLT $1.31
  • CPSS $8.32
  • Average True Range (ATR)
  • APLT 0.14
  • CPSS 0.46
  • MACD
  • APLT -0.04
  • CPSS 0.06
  • Stochastic Oscillator
  • APLT 25.53
  • CPSS 90.99

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

Share on Social Networks: